Sort
261,768 grants matching “gene therapy”
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$1,419,180Joseph Eric Levitt · Stanford University · UG3 · FY2019 · HL
Genes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC
$1,419,080Mary Beth Terry · Columbia University Health Sciences · R01 · FY2015 · CA
Gene Expression in Pediatric Arthritis
$1,419,030Children'S Hospital Med Ctr (Cincinnati) · P01 · FY2004 · AR
Epidemiology of Dementia in the Framingham Study
$1,418,912Sudha Seshadri · Boston University Medical Campus · R01 · FY2014 · AG
Antigen Specific Therapy in CNS Autoimmune Diseases
$1,418,846Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2006 · NS
Gene Discovery
$1,418,774Ira Pastan · Basic Sciences · Z01 · FY2007 · CA
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$1,418,589Sung-Yun Pai · Boston Children'S Hospital · U01 · FY2018 · AI
Retinal Circuit Development & Genetics
$1,418,568Tudor Badea · National Eye Institute · ZIA · FY2020 · EY
Functional genomic screens for molecular targets in cancer
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Clinical development of mechanism-based lymphoma therapies
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
HUMAN MELANOMA--ETIOLOGY, PROGRESSION AND THERAPY
$1,418,371Wistar Institute · P01 · FY2003 · CA
Sphingomab Mitigates the Multiple Pathologies of Age-Related Macular Degeneration
$1,418,276Roger Allen Sabbadini · Lpath Therapeutics, Inc. · R44 · FY2008 · EY
Oncogenic mechanisms and molecular targets in lymphoma
$1,418,261Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,418,261Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
RNA interference-based screens for molecular targets in cancer
$1,418,261Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Mechanism of action of omega-3 fatty acids in brain injury
$1,418,175Nicolas Guillermo Bazan · Lsu Health Sciences Center · RC2 · FY2009 · AT
Molecular Targets Development Program
$1,417,761James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease
$1,417,658Scott Scarneo · Eydis Bio, Inc. · R44 · FY2025 · HL
Center of Research Translation in Muscular Dystrophy Therapeutic Development
$1,417,545Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · P50 · FY2020 · AR
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
$1,417,351Howard S. Fox · University Of Nebraska Medical Center · U01 · FY2021 · DA
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$1,417,336Michael A Pulsipher · Children'S Hospital Of Los Angeles · U01 · FY2017 · AI
Impact of Stretching on Tumor growth and Metastasis
$1,417,327Lisbeth Berrueta Carrillo · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
The Phenomenology And Neurophysiology Of Juvenile Bipolar Disorder
$1,417,255Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2013 · MH